Kurz gefasst
Leitlinie in der Zeitschrift JAMA, erschienen am 19.08.2025. Verfasst von Ryan A Metcalf und 41 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Utah, Salt Lake City. Hauptthemen laut MEDLINE: Hemorrhage, Platelet Transfusion, Thrombocytopenia. Die Arbeit wurde bisher 145-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: CIHR.
Abstract (Originalsprache)
Importance Platelet transfusion is a frequent procedure with benefits and risks.
Objective
To provide recommendations in adult and pediatric populations in whom platelet transfusions are commonly performed. Evidence Review Grading of Recommendations Assessment Development and Evaluation (GRADE) methodology was applied to findings from 21 randomized trials and 13 observational studies in contexts of limited randomized clinical trial data. Transfusion strategies using fewer (restrictive) vs greater (liberal) amounts of platelets were compared.
Findings
Evidence demonstrated that restrictive transfusion strategies probably did not cause increases in mortality or bleeding relative to liberal strategies across predefined clinical populations. Exceedingly low incidence of spinal hematoma was identified in patients with thrombocytopenia undergoing lumbar puncture. Because definitions of restrictive strategies varied across trials, recommendations reflect practical guidance. The following recommendations are strong recommendations with high/moderate–certainty evidence. For hypoproliferative thrombocytopenia in nonbleeding patients receiving chemotherapy or undergoing allogeneic stem cell transplant, platelet transfusion is recommended when platelet count is less than 10 × 10 3 /μL. For consumptive thrombocytopenia in neonates without major bleeding, platelet transfusion is recommended when platelet count is less than 25 × 10 3 /μL. In patients undergoing lumbar puncture, platelet transfusion is recommended when platelet count is less than 20 × 10 3 /μL. In patients with consumptive thrombocytopenia due to Dengue without major bleeding, platelet transfusion is not recommended. The following recommendations are conditional recommendations with low/very low–certainty evidence. For hypoproliferative thrombocytopenia in nonbleeding adults undergoing autologous stem cell transplant or with aplastic anemia, prophylactic platelet transfusion is not recommended. In adults with consumptive thrombocytopenia without major bleeding, platelet transfusion is recommended when platelet count is less than 10 × 10 3 /μL. In adults undergoing central venous catheter placement in compressible anatomic sites, platelet transfusion is recommended when platelet count is less than 10 × 10 3 /μL. In adults undergoing interventional radiology, platelet transfusion is recommended when platelet count is less than 20 × 10 3 /μL for low-risk procedures and less than 50 × 10 3 /μL for high-risk procedures. For adults undergoing major nonneuraxial surgery, platelet transfusion is recommended when platelet count is less than 50 × 10 3 /μL. For patients without thrombocytopenia undergoing cardiovascular surgery in the absence of major hemorrhage, including those receiving cardiopulmonary bypass, platelet transfusion is not recommended. For nonoperative intracranial hemorrhage in adults with platelet count greater than 100 × 10 3 /μL, including those receiving antiplatelet agents, platelet transfusion is not recommended.
Conclusions
And Relevance A consistent pattern of evidence supports the implementation of restrictive platelet transfusion strategies. Restrictive strategies reduce risk of adverse reactions, mitigate platelet shortages, and reduce costs. It is good practice to consider overall clinical context and alternative therapies in the decision to perform platelet transfusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Utah, Salt Lake City.
- ARUP Laboratories, Salt Lake City, Utah.
- Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
- Departments of Clinical Epidemiology and Biostatistics and Medicine, McMaster University, Hamilton, Ontario, Canada.
- Canadian Blood Services, Toronto, Ontario, Canada.
- Department of Hematology, Sultan Qaboos University Hospital, University Medical City, Muscat, Oman.
Förderung
- CIHR
Zitieren
APA
Metcalf, R. A., Nahirniak, S., Guyatt, G., Bathla, A., White, S. K., Al-Riyami, A. Z., Jug, R. C., La Rocca, U., Callum, J. L., Cohn, C. S., DeAnda, A., DeSimone, R. A., Dubon, A., Estcourt, L. J., Filipescu, D. C., Fung, M. K., Goel, R., Hess, A. S., Hume, H. A., …, & Stanworth, S. J. (2025). Platelet Transfusion. JAMA, 334(7), 606. https://doi.org/10.1001/jama.2025.7529
Vancouver
Metcalf RA, Nahirniak S, Guyatt G, Bathla A, White SK, Al-Riyami AZ, et al. Platelet Transfusion. JAMA. 2025;334(7):606. doi:10.1001/jama.2025.7529
BibTeX
@article{Metcalf2025,
author = {Metcalf, Ryan A and Nahirniak, Susan and Guyatt, Gordon and Bathla, Aarti and White, Sandra K and Al-Riyami, Arwa Z and Jug, Rachel C and La Rocca, Ursula and Callum, Jeannie L and Cohn, Claudia S and DeAnda, Abe and DeSimone, Robert A and Dubon, Allan and Estcourt, Lise J and Filipescu, Daniela C and Fung, Mark K and Goel, Ruchika and Hess, Aaron S and Hume, Heather A and Kaufman, Richard M and Kranke, Peter and Louw, Vernon J and Møller, Morten H and Murphy, Michael F and Muszynski, Jennifer A and O'Kelly, Cian J and Pagano, Monica B and Patidar, Gopal K and Pavenski, Katerina and Poston, Jacqueline N and Saifee, Nabiha H and Stolla, Moritz and Szczepiorkowski, Zbigniew M and Tobian, Aaron A R and Uberoi, Raman and Waters, Jonathan and Williams, Brittney and Wood, Erica M and Zantek, Nicole D and Zeller, Michelle P and Grossman, Brenda J and Stanworth, Simon J},
title = {Platelet Transfusion},
journal = {JAMA},
year = {2025},
volume = {334},
number = {7},
pages = {606},
doi = {10.1001/jama.2025.7529}
}
EUVIMED